My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Pieris Pharmaceuticals, Inc. - Common Stock (NQ:PIRS)

13.60 UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 13, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Pieris Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Pieris Pharmaceuticals Surges On The Stock Market After Agreement With Genentech ↗

May 26, 2021

During yesterday's session, Pieris Pharmaceuticals (PIRS) soared in the financial markets after reaching a collaboration agreement with Genentech, in an operation that could be valued at $1.4 billion.

Via Talk Markets

Where Will The Pieris Pharmacuetical Stock Rally End? ↗

May 26, 2021

Shares of Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) on Tu...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 26, 2021

Gainers Pieris Pharmaceuticals (NASDAQ:PIRS) stock moved upwards by 20.74% to $4.54 during Wednesday's pre-market session. The market value of their outstanding shares...

Via Benzinga

The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing ↗

May 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 25) ESSA Pharma Inc. (NASDAQ:...

Via Benzinga

What's Going On With Pieris Pharmaceuticals Stock Today? ↗

May 25, 2021

Pieris Pharmaceuticals Inc (NASDAQ:PIRS) shares are tradin...

Via Benzinga

22 Stocks Moving in Wednesday's Pre-Market Session ↗

May 26, 2021

Gainers Nabriva Therapeutics plc (NASDAQ: NBRV) rose 48.8% to $2.20 in pre-market trading. Sinovant Sciences and Nabriva Therapeutics disclosed topline results from Phase 3 trial...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 25, 2021

Gainers Pieris Pharmaceuticals (NASDAQ:PIRS

Via Benzinga

Stocks Stunted Midday as Reopening Plays Weaken ↗

May 25, 2021

The major indexes have pared most of their pre-market gains, giving way to a somewhat static afternoon.

Via Talk Markets

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 25, 2021

Gainers Pieris Pharmaceuticals (NASDAQ:PIRS) stock moved upwards by 43.23% to $2.65 during Tuesday's regular session. As of 12:30 EST, Pieris Pharmaceuticals's...

Via Benzinga

Pieris Stock Surges on Development Pact with Genentech for Respiratory, Ophthalmology Settings ↗

May 25, 2021

Pieris Pharmaceuticals Inc (NASDAQ: PIRS) has entered into a multi-program research collaboration and license agreement with Genentech, a unit of ...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 25, 2021

Gainers AnPac Bio-Medical Science (NASDAQ:ANPC) shares increased by 27.99% to $5.99 during Tuesday's pre-market session. The market value of their outstanding shares...

Via Benzinga

Pieris Pharmaceuticals: Q1 Earnings Insights ↗

May 17, 2021

Shares of Pieris Pharmaceuticals (NASDAQ:PIRS) remained unaffected after the company reported Q1 results. Quarterly Results Earnings per share increased 0.00% over the past...

Via Benzinga

The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off ↗

May 15, 2021

Biotech stocks had a volatile ride in the week ended May 14, with stocks moving lower for much of the week before coming back up strongly in the final session. Some of the weakness may be traced back...

Via Talk Markets

Earnings Scheduled For May 17, 2021 ↗

May 17, 2021

Companies Reporting Before The Bell • Hycroft Mining Holding (NASDAQ:HYMC) is estimated to report earnings for its first quarter. • U.S. Well Services (NASDAQ:...

Via Benzinga

The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off ↗

May 15, 2021

Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the...

Via Benzinga

Earnings Preview: Pieris Pharmaceuticals ↗

May 14, 2021

On Monday, May 17, Pieris Pharmaceuticals (NASDAQ:PIRS) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 12, 2021

Gainers 180 Life Sciences (NASDAQ:ATNF) shares increased by 27.31% to $12.4 during Monday's regular session. Trading volume for 180 Life Sciences's stock is 29.3...

Via Benzinga

42 Stocks Moving In Monday's Mid-Day Session ↗

April 12, 2021

Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 44.8% to $8.05 after the company's 13D filing showed that Modell's Sporting Goods had reported a stake...

Via Benzinga

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

55 Biggest Movers From Yesterday ↗

April 13, 2021

Gainers Celcuity Inc. (NASDAQ: CELC) jumped 29.4% to settle at $27.94. Celcuity shares climbed 51% on Friday after the company announced a worldwide licensing agreement with...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.